With machine learning technology, EasyScan GO automatically and accurately detects malaria parasites within minutes, providing important decision support to microscopists and enabling effective tracking of the mutating disease through standardized diagnoses. The future of automated quality diagnosis begins now.
Global Good and Element Inc. to Develop Biometric Identification Technology for Infants and Children
Powered by deep learning algorithms, a modern form of artificial intelligence, that use existing cameras on mobile devices, the biometric application could—for the first time—enable health systems to recognize and follow patients from birth to old age.
The Invention Science Fund (ISF) Incubator, the new startup arm at Intellectual Ventures, and Utah-based Technium announced today a strategic relationship to accelerate the creation of high-impact technology startup companies.
Intellectual Ventures’ Global Good Fund and GE (NYSE: GE), have signed a licensing agreement with the diagnostics technology company Access Bio (KOSDAQ: 950130) to manufacture and distribute innovative diagnostic technologies that will help global health workers to more rapidly identify asymptomatic malaria in low-resource regions around the world.
The partnership will combine Global Good’s assay platform with Biopromic’s proprietary technologies in sample preparation and high-sensitivity antibodies to improve the accessibility of accurate TB testing in low- and middle-income countries.
Dominion Harbor Enterprises today announced the acquisition of over 1,000 patent families from Kodak’s iconic portfolio of patented technologies. This extensive portfolio has been acquired from Intellectual Ventures (IV).
QuantuMDx Group announced an assay co-development and commercialization agreement with The Global Good Fund, managed by Intellectual Ventures, to develop a rapid, low-cost and mobile diagnostic test for the detection of human papillomavirus (HPV).
Intellectual Ventures (IV) announces the promotion of senior vice president and deputy chief financial officer Larry Froeber to the chief financial officer role.
Intellectual Ventures (IV) announced the sale of a seminal portfolio of patents in the online gaming space to an affiliate of Equitable IP Holdings.
Global Good Fund, the Feinstein Institute and Sanguistat Announce New Bioelectronic Treatment Initia
The Global Good Fund, The Feinstein Institute for Medical Research at Northwell Health and Sanguistat, Inc, are partnering on clinical trials of the Neural Tourniquet to evaluate the efficacy of bioelectronic medicine in treating blood loss associated with postpartum hemorrhage.
Twitter | Follow Us »
Researchers grew sheets of genetically altered skin cells in the lab and used them to treat a boy with life-threate… twitter.com/i/web/status/9…